Description: Control Bionics Limited designs, manufactures, and sells communication technologies that allow users to operate and communicate through a computer using their thoughts and neural signals. It offers GridPad Trilogy that offers users additional switch ports, built-in IR, improved speaker output, and a 12-hour battery life; NeuroNode Trilogy, a solution for those living with paralysis and loss of speech; and Control Bionics Complete Communication System, an out of the box solution for those living with paralysis and loss of speech. The company also provides support and warranty services. Its products are used by people suffering from diseases that hamper their communication ability, such as multiple sclerosis and cerebral palsy, as well as spinal cord injuries. The company was founded in 2005 and is based in Surrey Hills, Australia.
Home Page: www.controlbionics.com
CBL Technical Analysis
Columbia Funds Series Trust I
,
Phone:
800-345-6611
Officers
| Name | Title |
|---|---|
| Mr. Peter Shann Ford | Founder, Interim CEO, Exec. Director & Director of Innovation |
| Mr. Robert William Wong | Exec. Director |
| Mr. Todd Tyler | US Country Mang. |
| Dominik Kucera | Interim Chief Financial Officer |
| Mr. James Schorey | Chief Technology Officer |
| Ms. Meagan Koeneman | Sales Director |
| Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLaw | Company Sec. |
Exchange: AU
Country: AU : Australia
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0244 |
| Price-to-Sales TTM: | 2.537 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |